XOMA Corporation
XOMA
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stagā¦ read more
Healthcare
Biotechnology
37 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$31.37
Price-0.70%
-$0.22
1Y
Price
Market Cap
$375.402m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financials Overview
Key metrics over the past few years-
EBITDA Margin-
Net Profit Margin-
Free Cash Flow MarginRevenue
$36.537m
-
1y CAGR-
3y CAGR-
5y CAGREarnings
-$2.859m
-
1y CAGR-
3y CAGR-
5y CAGREPS
$12.10
-
1y CAGR-
3y CAGR-
5y CAGRBook Value
$84.629m
$212.750m
Assets$128.121m
Liabilities$114.452m
DebtDebt to Assets
53.8%
-6.8x
Debt to EBITDAFree Cash Flow
-$6.686m
-
1y CAGR-
3y CAGR-
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company